Education
About Us
Working with TipRanks
Follow Us
Scilex Holding Company (SCLX)
NASDAQ:SCLX
SCLX Stock Chart & Stats
$14.61
-$0.03(-6.37%)
At close: 4:00 PM EST
$14.61
-$0.03(-6.37%)
Day’s Range― - ―
52-Week Range$3.60 - $34.27
Previous CloseN/A
Volume735.36K
Average Volume (3M)279.94K
Market Cap
$130.68M
Enterprise ValueN/A
Total Cash (Recent Filing)$878.00K
Total Debt (Recent Filing)$67.67M
Price to Earnings (P/E)―
Beta0.47
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.62
Shares Outstanding8,491,267
10 Day Avg. Volume250,675
30 Day Avg. Volume279,942
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)-0.54
Price to Sales (P/S)1.83
P/FCF Ratio5.36
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Scilex Holding Company News
SCLX FAQ
What was Scilex Holding Company’s price range in the past 12 months?
Scilex Holding Company lowest stock price was $3.60 and its highest was $34.27 in the past 12 months.
What is Scilex Holding Company’s market cap?
Scilex Holding Company’s market cap is $130.68M.
When is Scilex Holding Company’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Scilex Holding Company’s earnings last quarter?
Currently, no data Available
Is Scilex Holding Company overvalued?
According to Wall Street analysts Scilex Holding Company’s price is currently Overvalued.
Does Scilex Holding Company pay dividends?
Scilex Holding Company does not currently pay dividends.
What is Scilex Holding Company’s EPS estimate?
Scilex Holding Company’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Scilex Holding Company have?
Scilex Holding Company has 8,491,267 shares outstanding.
What happened to Scilex Holding Company’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Scilex Holding Company?
Currently, no hedge funds are holding shares in SCLX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Scilex Holding Company Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
Hedge Fund Trend
Decreased
By 29.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.8%
Last 30 Days ▲ 0.8%
Last 30 Days ▲ 0.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-61.42%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-19.89%
Trailing 12-Months
Company Description
Scilex Holding Company
Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid management products for the treatment of acute and chronic pain. Its commercial product is ZTlido 1.8%, a prescription lidocaine topical product for the relief of neuropathic pain related with post-herpetic neuralgia, which is a form of post-shingles nerve pain. It also offers SP-102, a viscous gel formulation of corticosteroid for epidural injections that is in a Phase III clinical trial to treat lumbosacral radicular pain; SP-103, which is in Phase II clinical trail for the treatment of low back pain; and SP-104, a novel low-dose delayed-release naltrexone hydrochloride formulation that has completed Phase I clinical trial for the treatment of fibromyalgia. The company is headquartered in Palo Alto, California. Scilex Holding Company is a subsidiary of Sorrento Therapeutics, Inc.